Baystate Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Baystate Wealth Management's BSX Position: Q4 2023 in Review
Baystate Wealth Management increased its Boston Scientific (BSX) stake by 6% in Q4 2023, buying an estimated $3.68K and bringing the position to 1,224 shares worth $70.8K. The position accounts for 0.01% of the portfolio, ranked #321.
Baystate Wealth Management first reported a position in BSX in Q1 2017 and has held it in 28 quarters since. 1,150 funds tracked by Wall St. Rank hold BSX as of Q4 2023.
- Baystate Wealth Management held 1,224 shares of Boston Scientific worth $70.8K as of Q4 2023.
- Baystate Wealth Management bought 69 Boston Scientific shares in Q4 2023, an estimated $3.68K.
- Boston Scientific made up 0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #321 holding.
- Baystate Wealth Management first reported a position in Boston Scientific in Q1 2017 and has held it in 28 quarters since.
- 1,150 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.
Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.